한국어
English
日本語
中文(简体)Summary
- Main use
- Adjunct therapy for toxic liver disease and chronic hepatitis
- Who takes it
- Adults
- Adult dose
- Tablets, liquid, suspension: 35-140 mg of silymarin (or 15-60 mg of silibinin) per dose, taken three times a day. Capsules: Initial dose of 140 mg (or 60 mg of silibinin) per dose, taken three times daily, with a maintenance dose of 70 mg (or 30 mg of silibinin) per dose, taken three times a day. Or, 140 mg (or 60 mg of silibinin) per dose, taken twice daily.
Ingredients
- Manufacturer
- 영일제약(주)
Efficacy & effects
Adjunct therapy for toxic liver disease and chronic hepatitis
- Toxic liver disease
- chronic hepatitis
- cirrhosis
View approved original textHide original text
This medication is used as an adjunct therapy for liver diseases such as toxic liver disease, chronic hepatitis, and cirrhosis. It also helps to protect liver cells and improve liver function. The tablet, liquid, and suspension forms are also applicable in treatments related to liver cell protection. Capsules are primarily used as adjunct therapy for toxic liver disease, chronic hepatitis, and cirrhosis. These various formulations contribute to alleviating patients' symptoms.
How to take
Adult dose
Tablets, liquid, suspension: 35-140 mg of silymarin (or 15-60 mg of silibinin) per dose, taken three times a day. Capsules: Initial dose of 140 mg (or 60 mg of silibinin) per dose, taken three times daily, with a maintenance dose of 70 mg (or 30 mg of silibinin) per dose, taken three times a day. Or, 140 mg (or 60 mg of silibinin) per dose, taken twice daily.
Precautions
This medication should not be taken by patients with severe biliary obstruction. Additionally, individuals who have allergic reactions to this medication should avoid use. It is not safe for children under 12 years of age to use this medication. This medication contains lactose; therefore, individuals with lactose intolerance, genetic lactose deficiency, or glucose-galactose malabsorption should refrain from taking it. Pregnant or breastfeeding women must consult a doctor or pharmacist before taking this medication. If symptoms such as stomach pain or diarrhea occur while taking this medication, consumption should be immediately stopped and a healthcare professional consulted. In case of an allergic reaction, consumption should also be stopped immediately and a healthcare provider should be notified. Dosage and administration should strictly follow the prescribed guidelines, and consultation with a healthcare professional is essential if jaundice symptoms present. If symptoms do not improve after one month or if used for a prolonged period, consultation with a doctor or pharmacist is important. This medication should be kept out of reach of children and stored in a cool, dry place away from direct sunlight. Medicines should be kept in their original container and should not be transferred to another container to maintain quality. Finally, this medication contains the dye Tartrazine (Yellow No. 4), and those allergic or sensitive to this ingredient should take care when using it.
Side effects and when to seek care immediately
Serious side effects
Jaundice
Mild side effects
Stomach pain, diarrhea, allergic reactions (including hypersensitivity)
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a sealed container to prevent contact with air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help ensure the medication's effectiveness.
Appearance and packaging
Appearance
Red-brown round coated tablets.
Package unit
Self-packaging unit
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.